Real-time enrollment status for this sickle cell disease, hemolytic anemia clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 12:27 AM UTC
| NCT Number | NCT07566494 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease, Hemolytic Anemia |
| Phase | PHASE1 |
| Target Enrollment | 25 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | August 24, 2026 (Aug 24, 2026) |
As of October 14, 2026: Clinical trial NCT07566494 is currently recruiting participants. This phase1 study for sickle cell disease, hemolytic anemia is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07566494 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07566494 was last updated Aug 24, 2026 (August 24, 2026). HelloStudys verifies this status automatically.